Skip to content

Clinical trials

Phase 2 Non-alcoholic Fatty Liver Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Phase: Phase 2 Clear all

295 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20035
20051
20064
20075
20086
20092
20107
20116
201210
201311
20148
201518
201618
201718
201812
201935
202022
202128
202218
202327
202414
20259
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed181
Terminated42
Recruiting25
Unknown status17
Active, not recruiting15
Withdrawn8
Not yet recruiting7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)12
Gilead Sciences11
Novartis Pharmaceuticals7
Pfizer6
University of California, San Diego6
Zydus Therapeutics Inc.6
Bristol-Myers Squibb5
Merck Sharp & Dohme LLC5
Tanta University5
AstraZeneca4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease295
Fatty Liver51
Diabetes Mellitus, Type 223
Liver Cirrhosis22
Fibrosis21
Liver Diseases18
Obesity16
Insulin Resistance13
Diabetes Mellitus11
Hypertriglyceridemia7

Trials

Showing 51 to 75 of 295. Each trial links to its page on Pharma Observatory.

195 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.